DDP733

DRUG2 trials

Sponsors

Dynogen Pharmaceuticals

Conditions

Irritable Bowel SyndromeIrritable Bowel Syndrome With Constipation

Phase 2

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c

CompletedNCT00215566

Dynogen PharmaceuticalsIrritable Bowel Syndrome, Irritable Bowel Syndrome With Constipation

Start: 2005-09-30Target: 90Updated: 2007-05-28

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Dynogen PharmaceuticalsIrritable Bowel Syndrome

Start: 2007-10-31Target: 360Updated: 2008-04-08